TiUnite

TiUnite

TiUnite

Product catalog summary
Introduction
The document presents a comprehensive meta-analysis of the TiUnite implant surface, highlighting its effectiveness in supporting peri-implant health, bone maintenance, and overall treatment success over the long term.

Key Findings
  • Implant Success Rates: The TiUnite implant surface shows a 95.1% success rate at the implant level over 10 years and over 99% at the implant level after 1 year.
  • Bone Maintenance: The marginal bone level change from implant insertion at a 5-year follow-up is minimal, with a change of -0.9 mm considered successful.
  • Peri-implantitis Prevalence: Low prevalence of peri-implantitis is reported, with a low estimate of 1.36%.
  • Study Scope: The analysis includes 106 prospective studies, covering 12,803 TiUnite implants and 4,694 patients.

Methodology
The meta-analysis screened 32,519 publications and included all patients with a TiUnite implant evaluated in clinical studies with a minimum of 20 patients and 12 months post-loading.

Conclusion
The TiUnite implant surface promotes a healthy bone response during the first year, which remains stable over the long term. There is strong evidence of high implant survival and low rates of peri-implantitis with TiUnite surface implants.

Additional Information
For more details, visit nobelbiocare.com/tiunite. Note that some products may not be available in all markets, and the device is restricted to sale by or on the order of a licensed dentist.
See more

Catalog excerpts

TiUnite-1

Setting the scientific standard. Again. The largest meta-analysis of a single implant brand unequivocally shows that the TiUnite implant surface supports peri-implant health, bone maintenance and overall treatment success, long term. Excellent implant survival rates, short- and long-term Good bone maintenance -1 mm Marginal bone level change from implant insertion at 5-year follow-up * Results of regression analysis. Details can be found in full publication. † Of 106 studies, 47 reported biological complications. Of these 47 papers, 19 reported cases of peri-implantitis in 5.2% of patients (64/1229). The authors postulated that, if peri-implantitis did not occur in studies where it was not explicitly reported, its prevalence would be 1.36%. ‡ Misch CE, Perel ML, Wang HL, et al. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. I

 Open the catalog to page 1
TiUnite-2

The largest meta-analysis of a single implant brand prospective studies publications screened No cherry picking Includes all patients with a TiUnite implant prospectively evaluated in a clinical study with a minimum of 20 patients and 12 months post-loading. 99TiUnite promotes a healthy bone response during the first year which remains stable over the long term. 99Strong evidence of high implant survival with TiUnite surface. 99Low rates of reported peri-implantitis in patients with TiUnite surface implants. Karl M, Albrektsson T. Clinical performance of dental implants with a moderately rough...

 Open the catalog to page 2

All Nobel Biocare Services AG catalogs and technical brochures

  1. X-Guide

    2  Pages

  2. NobelPearl™

    8  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.